耳科手术后阿片类药物处方模式:基于人群的研究
该研究基于加拿大安大略省所有医院2012年7月至2019年3月的回顾性人群数据,分析7类耳科手术后的阿片类药物处方模式。结果显示不同手术类型平均吗啡毫克当量(MME)差异大,半规管阻塞术和乳突切除术与较高剂量相关,哮喘、COPD、心梗、糖尿病及物质相关成瘾障碍也是高剂量预测因素,年度MME从2017-2018到2018-2019急剧下降。
要点
- 耳科手术后阿片处方量变异大,半规管阻塞术和乳突切除术剂量较高。
- 物质相关成瘾障碍使高剂量阿片处方风险增加(OR 2.59)。
- 年度总MME在2018-2019较上一年度急剧下降。
核心结论
- 耳科手术后阿片类药物处方量大且变异显著,需进一步研究限制良好处方管理的障碍。
研究设计与样本
- 回顾性人群描述性研究,纳入加拿大安大略省所有医院2012年7月1日至2019年3月31日接受晚期耳科手术的患者,构建7个手术队列。
主要发现
- 各手术平均±标准差MME:鼓室成形术伴或不伴听骨链成形术246.77±1380.78;上鼓室切开/局限乳突切除术283.32±956.10;乳突切除术280.56±1018.50;半规管阻塞术328.61±1090.86;镫骨切除术164.64±657.18;骨植入式助听器插入326.11±1054.66;人工耳蜗植入200.87±639.93。
- 半规管阻塞术(OR 1.69 [95% CI, 1.16-2.48])和乳突切除术(OR 1.50 [95% CI, 1.36-1.66])与较高阿片剂量相关,参照为鼓室成形术-听骨链成形术。
- 哮喘(OR 1.24 [95% CI, 1.12-1.38])、慢性阻塞性肺疾病(OR 1.29 [95% CI, 1.12-1.47])、心肌梗死(OR 1.33 [95% CI, 1.05-1.68])、糖尿病(OR 1.22 [95% CI, 1.08-1.39])及物质相关和成瘾障碍(OR 2.59 [95% CI, 1.67-4.00])与较高阿片处方剂量相关。
- 年度总MME从2017-2018到2018-2019显示急剧下降。
临床怎么用
- 耳科手术后应关注阿片处方剂量,尤其对半规管阻塞术、乳突切除术及合并哮喘、COPD、心梗、糖尿病或物质成瘾障碍的患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine postoperative opioid-prescribing patterns following otologic surgery. STUDY DESIGN: Retrospective population-based descriptive study. SETTING: All hospitals in the Canadian province of Ontario. METHODS: Of all patients with advanced ear surgery between July 1, 2012, and March 31, 2019, 7 cohorts were constructed: tympanoplasty with or without ossiculoplasty (n = 7812), atticotomy/limited mastoidectomy (n = 1371), mastoidectomy (n = 3717), semicircular canal occlusion (SCO; n = 179), stapedectomy (n = 2735), bone-implanted hearing aid insertion (n = 280), and cochlear implant (n = 2169). Prescriptions filled for narcotics postoperatively were calculated per morphine milligram equivalent (MME) opioid dose. Multivariable regression was used to determine predictors of higher opioid doses. RESULTS: The mean ± SD MMEs prescribed were as follows: tympanoplasty with or without ossiculoplasty, 246.77 ± 1380.78; atticotomy/limited mastoidectomy, 283.32 ± 956.10; mastoidectomy, 280.56 ± 1018.50; SCO, 328.61 ± 1090.86; stapedectomy, 164.64 ± 657.18; bone-implanted hearing aid insertion, 326.11 ± 1054.66; and cochlear implant, 200.87 ± 639.93. SCO (odds ratio [OR], 1.69 [95% CI, 1.16-2.48]) and mastoidectomy (OR, 1.50 [95% CI, 1.36-1.66]) were associated with higher opioid doses than tympanoplasty-ossiculoplasty. Asthma (OR, 1.24 [95% CI, 1.12-1.38]), chronic obstructive pulmonary disease (OR, 1.29 [95% CI, 1.12-1.47]), myocardial infarction (OR, 1.33 [95% CI, 1.05-1.68]), diabetes (OR, 1.22 [95% CI, 1.08-1.39]), and substance-related and addictive disorders (OR, 2.59 [95% CI, 1.67-4.00]) were associated with higher opioid doses prescribed. Overall MME prescribed by year demonstrates a sharp drop from 2017-2018 to 2018-2019. CONCLUSION: This large comprehensive population study provides insight into the prescribing patterns following otologic surgery. The large amounts prescribed and substantial variation require further study to determine barriers that limit good opioid-prescribing stewardship in the postoperative period.
引用
- Kirubalingam K, Nguyen P, Klar G, et al. Opioid Prescriptions Following Otologic Surgery: A Population-Based Study. Otolaryngol Head Neck Surg. 2021. PMID: 34582291. doi:10.1177/01945998211045364
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。